- Home
- DMF vs ALEC Comparison
DMF vs ALEC Comparison
Compare DMF & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMF
- ALEC
- Stock Information
- Founded
- DMF 1988
- ALEC 2013
- Country
- DMF United States
- ALEC United States
- Employees
- DMF N/A
- ALEC N/A
- Industry
- DMF Finance/Investors Services
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DMF Finance
- ALEC Health Care
- Exchange
- DMF Nasdaq
- ALEC Nasdaq
- Market Cap
- DMF 152.2M
- ALEC 162.6M
- IPO Year
- DMF N/A
- ALEC 2019
- Fundamental
- Price
- DMF $7.18
- ALEC $1.23
- Analyst Decision
- DMF
- ALEC Buy
- Analyst Count
- DMF 0
- ALEC 7
- Target Price
- DMF N/A
- ALEC $4.10
- AVG Volume (30 Days)
- DMF 60.7K
- ALEC 565.4K
- Earning Date
- DMF 01-01-0001
- ALEC 05-07-2025
- Dividend Yield
- DMF 2.66%
- ALEC N/A
- EPS Growth
- DMF N/A
- ALEC N/A
- EPS
- DMF 0.15
- ALEC N/A
- Revenue
- DMF N/A
- ALEC $100,558,000.00
- Revenue This Year
- DMF N/A
- ALEC N/A
- Revenue Next Year
- DMF N/A
- ALEC $40.79
- P/E Ratio
- DMF $45.13
- ALEC N/A
- Revenue Growth
- DMF N/A
- ALEC 3.60
- 52 Week Low
- DMF $5.37
- ALEC $1.20
- 52 Week High
- DMF $6.79
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- DMF 46.06
- ALEC 34.56
- Support Level
- DMF $7.13
- ALEC $1.26
- Resistance Level
- DMF $7.29
- ALEC $1.36
- Average True Range (ATR)
- DMF 0.07
- ALEC 0.09
- MACD
- DMF -0.02
- ALEC 0.00
- Stochastic Oscillator
- DMF 17.24
- ALEC 7.89
About DMF BNY Mellon Municipal Income Inc.
BNY Mellon Municipal Income, Inc. is a non-diversified closed-end management investment company. Its investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. The fund invests in municipal obligations that are rated investment grade and have maturities of less than one year. The company targets to invest in the sector such as education, pre-refunded muni, utility, transportation, healthcare, special tax, state/territory general obligations, industry revenue, and pollution control.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.